A long-term study to evaluate safety and efficacy of pregabalin in the treatment of postherpetic neuralgia.

Trial Profile

A long-term study to evaluate safety and efficacy of pregabalin in the treatment of postherpetic neuralgia.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Nov 2016

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Postherpetic neuralgia
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Nov 2016 Results of a retrospective analysis from NCT00394901, NCT00553475, NCT00407745, NCT00424372, NCT00553280, NCT01202227 studies, published in the Clinical Drug Investigation
    • 28 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Sep 2008 Patient number changed from 150 to 126 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top